1. Practical Strategies to Guideline-Recommended Biomarker Testing in NSCLC

3. Guidelines for Molecular Testing: CAP/IASLC/AMP and ASCO® Endorsement

4. ALK and ROS1

5. BRAF

6. Guidelines for Molecular Testing: NCCN

7. PD-L1

8. Resistance

9. Tissue Type at Diagnosis

10. Bespoke vs Reflex Testing

11. Communication

12. Patient Case

13. Patient Case

14. Patient Case

15. Patient Case

16. Patient Case

17. Resistance Mechanisms

18. Patient Case

19. FLAURA Trial: Study Design

20. FLAURA Trial: PFS and OS

21. FLAURA Trial: Resistance With Osimertinib

22. Liquid Biopsy

23. Emerging Molecular Biomarkers

24. Future of Biomarker Testing

25. Abbreviations

26. Abbreviations (cont)